NEVIRAPINE
Generic: NEVIRAPINE
Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
NEVIRAPINEActive Substance
2014-10-27Original Approval
NEVIRAPINE is FDA application ANDA205651, sponsored by MYLAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
1,116 reports
2
DRUG RESISTANCE
1,033 reports
3
VIROLOGIC FAILURE
800 reports
4
VIRAL MUTATION IDENTIFIED
696 reports
5
DEATH
501 reports
6
EXPOSURE DURING PREGNANCY
463 reports
7
HIV INFECTION
432 reports
8
DRUG INEFFECTIVE
406 reports
9
PATHOGEN RESISTANCE
386 reports
10
TREATMENT FAILURE
335 reports